Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10.

Literature DB >> 2571566

Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10.

D M Schonk¹, H J Kuijpers, E van Drunen, C H van Dalen, A H Geurts van Kessel, R Verheijen, F C Ramaekers.

Abstract

The antigen recognized by the monoclonal antibody Ki-67 is a proliferation-related nucleolus-associated constituent used as a marker for cycling cells in tumor diagnosis. Antibody Ki-67 reacts with human proliferating cells, but not with hamster and mouse cells. Expression of the Ki-67 antigen was studied in a panel of human-rodent somatic cell hybrids. The results indicate that a gene involved in the expression of the antigen is located on chromosome 10.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 1989 PMID： 2571566 DOI： 10.1007/BF00285178

Source DB: PubMed Journal: Hum Genet ISSN： 0340-6717 Impact factor: 4.132

13 in total

1. Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables.

Authors: N J Barnard; P A Hall; N R Lemoine; N Kadar
Journal: J Pathol Date: 1987-08 Impact factor: 7.996

2. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors: J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal: J Immunol Date: 1984-10 Impact factor: 5.422

3. The Giemsa-11 technique for species-specific chromosome differentiation. A simple stain modification leading to dependable direct and sequential staining procedures.

Authors: C H Buys; G H Aanstoot; A J Nienhaus
Journal: Histochemistry Date: 1984

4. Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme.

Authors: M Fujimoto; D W Fults; G A Thomas; Y Nakamura; M P Heilbrun; R White; J L Story; S L Naylor; K S Kagan-Hallet; P J Sheridan
Journal: Genomics Date: 1989-02 Impact factor: 5.736

5. Toward a complete linkage map of the human X chromosome: regional assignment of 16 cloned single-copy DNA sequences employing a panel of somatic cell hybrids.

Authors: P Wieacker; K E Davies; H J Cooke; P L Pearson; R Williamson; S Bhattacharya; J Zimmer; H H Ropers
Journal: Am J Hum Genet Date: 1984-03 Impact factor: 11.025

6. Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67.

Authors: F Giangaspero; C Doglioni; M T Rivano; S Pileri; J Gerdes; H Stein
Journal: Acta Neuropathol Date: 1987 Impact factor: 17.088

7. Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis.

Authors: W A Franklin; G B McDonald; H O Stein; K C Gatter; D P Jewell; L C Clarke; D Y Mason
Journal: Hum Pathol Date: 1985-11 Impact factor: 3.466

8. Human lens gamma-crystallin sequences are located in the p12-qter region of chromosome 2.

Authors: J T den Dunnen; R J Jongbloed; A H Geurts van Kessel; J G Schoenmakers
Journal: Hum Genet Date: 1985 Impact factor: 4.132

Review 9. Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview.

Authors: F C Ramaekers; J J Puts; O Moesker; A Kant; A Huysmans; D Haag; P H Jap; C J Herman; G P Vooijs
Journal: Histochem J Date: 1983-07

10. Ki-67 detects a nuclear matrix-associated proliferation-related antigen. I. Intracellular localization during interphase.

Authors: R Verheijen; H J Kuijpers; R O Schlingemann; A L Boehmer; R van Driel; G J Brakenhoff; F C Ramaekers
Journal: J Cell Sci Date: 1989-01 Impact factor: 5.285

23 in total

1. Aberrant p27kip1 expression in endocrine and other tumors.

Authors: R V Lloyd; L Jin; X Qian; E Kulig
Journal: Am J Pathol Date: 1997-02 Impact factor: 4.307

2. Extensive cellular heterogeneity of X inactivation revealed by single-cell allele-specific expression in human fibroblasts.

Authors: Marco Garieri; Georgios Stamoulis; Xavier Blanc; Emilie Falconnet; Pascale Ribaux; Christelle Borel; Federico Santoni; Stylianos E Antonarakis
Journal: Proc Natl Acad Sci U S A Date: 2018-12-03 Impact factor: 11.205

3. Estimation of the proliferative activity of human breast cancer tissue by means of the Ki-67 and MIB-1 antibodies--comparative studies on frozen and paraffin sections.

Authors: W Remmele; V Mühlfait; H G Keul
Journal: Virchows Arch Date: 1995 Impact factor: 4.064

4. Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer.

Authors: Armelle Corpet; Leanne De Koning; Joern Toedling; Alexia Savignoni; Frédérique Berger; Charlène Lemaître; Roderick J O'Sullivan; Jan Karlseder; Emmanuel Barillot; Bernard Asselain; Xavier Sastre-Garau; Geneviève Almouzni
Journal: EMBO J Date: 2010-12-21 Impact factor: 11.598

5. A comparative study of cell proliferation markers in breast carcinomas.

Authors: A S Leong; S Vinyuvat; C Suthipintawong; J Milios
Journal: Clin Mol Pathol Date: 1995-04

6. Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses' Health Study.

Authors: Megan A Healey; Kelly A Hirko; Andrew H Beck; Laura C Collins; Stuart J Schnitt; A Heather Eliassen; Michelle D Holmes; Rulla M Tamimi; Aditi Hazra
Journal: Breast Cancer Res Treat Date: 2017-08-08 Impact factor: 4.872

7. p53, HER2 and tumor cell apoptosis correlate with clinical outcome after neoadjuvant bevacizumab plus chemotherapy in breast cancer.

Authors: Sherry X Yang; Seth M Steinberg; Dat Nguyen; Sandra M Swain
Journal: Int J Oncol Date: 2011-03-09 Impact factor: 5.650